anti-CD261 / TRAIL R1 antibody [DR-4-02] (FITC)
![anti-CD261 / TRAIL R1 antibody [DR-4-02] (FITC)](/upload/image/products/ARG53804_FACS_1_210_205.jpg)
![anti-CD261 / TRAIL R1 antibody [DR-4-02] (FITC)](/upload/image/products/ARG53804_FACS_1.jpg)
Key features and details
- 产品描述:
- 反应物种:
- 应用:
- 特异性:
- 宿主:
- 克隆:
- 克隆号:
- 同位型:
- 靶点名称:
-
Brand:
Product Details
| 产品描述 | FITC-conjugated Mouse Monoclonal antibody [DR-4-02] recognizes CD261 / TRAIL R1 |
|---|---|
| 反应物种 | Hu |
| 应用 | FACS |
| 特异性 | The clone DR-4-02 recognizes TRAIL-R1 (DR4), a human death receptor 4 (468 amino acids) expressed in most human tissues (spleen, peripheral blood leucocytes, thymus) and in a variety of tumour-derived cell lines. |
| 宿主 | Mouse |
| 克隆 | Monoclonal |
| 克隆号 | DR-4-02 |
| 同位型 | IgG1 |
| 靶点名称 | CD261 / TRAIL R1 |
| 抗原物种 | Human |
| 抗原 | Fusion protein containing the extracellular part of TRAIL-R1 and the constant part of the heavy chain of the human IgG1. |
| 偶联标记 | FITC |
| 別名 | TNF-related apoptosis-inducing ligand receptor 1; CD antigen CD261; TRAILR-1; DR4; Tumor necrosis factor receptor superfamily member 10A; CD261; Death receptor 4; APO2; TRAIL receptor 1; TRAIL-R1; TRAILR1 |
| 应用建议 |
| ||||
|---|---|---|---|---|---|
| 应用说明 | * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. |
| 形式 | Liquid |
|---|---|
| 纯化说明 | The purified antibody is conjugated with Fluorescein isothiocyanate (FITC) under optimum conditions. The reagent is free of unconjugated FITC and adjusted for direct use. No reconstitution is necessary. |
| 缓冲液 | PBS, 15 mM Sodium azide and 0.2% (w/v) high-grade protease free BSA |
| 抗菌剂 | 15 mM Sodium azide |
| 稳定剂 | 0.2% (w/v) high-grade protease free BSA |
| 浓度 | 0.1 mg/ml |
| 存放说明 | Aliquot and store in the dark at 2-8°C. Keep protected from prolonged exposure to light. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. |
| 注意事项 | For laboratory research only, not for drug, diagnostic or other use. |
| 数据库连接 | Swiss-port # O00220 Human Tumor necrosis factor receptor superfamily member 10A |
|---|---|
| 基因名称 | TNFRSF10A |
| 全名 | tumor necrosis factor receptor superfamily, member 10a |
| 背景介绍 | TRAIL-R1 (CD261, DR4) is a type I transmembrane protein, also called TRAIL receptor 1. The ligand for this DR4 death receptor has been identified and termed TRAIL, which is a member of the TNF family. DR4, as many other receptors (Fas, TNFR1, etc.), mediates apoptosis and NF kappaB activation in many cells and tissues. Apoptosis, a programmed cell death, is a operating process in normal cellular differentiation and development of multicellular organisms. Apoptosis is induced by coupled of certain cytokines (TNF family - TNF, Fas ligand) and their death domain containing receptors (TNFR1, Fas receptor). |
| 生物功能 | Receptor for the cytotoxic ligand TNFSF10/TRAIL. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. Promotes the activation of NF-kappa-B. [UniProt] |
| 研究领域 | Cell Biology and Cellular Response antibody; Cell Death antibody; Immune System antibody |
| 预测分子量 | 50 kDa |
ARG53804 anti-CD261 / TRAIL R1 antibody [DR-4-02] (FITC) FACS image
Flow Cytometry: CD261-transfected HEK293 cells stained with ARG53804 anti-CD261 / TRAIL R1 antibody [DR-4-02] (FITC).
克隆号文献
Systems analysis of apoptosis protein expression allows the case-specific prediction of cell death responsiveness of melanoma cells.
Evaluating the effect of therapeutic stem cells on TRAIL resistant and sensitive medulloblastomas.
FACS / Human
Cisplatin and a potent platinum(IV) complex-mediated enhancement of TRAIL-induced cancer cells killing is associated with modulation of upstream events in the extrinsic apoptotic pathway.
ICC/IF / Human
Scatter factor protects tumor cells against apoptosis caused by TRAIL.
IP /
Matrix protein CCN1 is critical for prostate carcinoma cell proliferation and TRAIL-induced apoptosis.
New Products
